Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Biotech

+ Watchlist
BBBIOUI:LX
529.62
USD
13.20
2.56%
As of 08:32:00 ET on 08/27/2015.
Fund Type
SICAV
52Wk Range
395.53 - 615.14
1 Yr Return
23.79%
YTD Return
11.42%
Previous Close
516.42
52Wk Range
395.53 - 615.14
1 Yr Return
23.79%
YTD Return
11.42%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 08/27/2015)
529.62
Total Assets (m USD) (on 08/27/2015)
91.360
Inception Date
03/31/2009
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
CHRISTIAN LACH
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
1.65%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 63.00 k 8.27 m 7.74
Regeneron Pharmaceuticals Inc 14.90 k 8.25 m 7.73
Gilead Sciences Inc 68.00 k 8.01 m 7.51
Amgen Inc 38.87 k 6.86 m 6.43
Biogen Inc 18.00 k 5.74 m 5.37
Illumina Inc 19.30 k 4.23 m 3.96
Alexion Pharmaceuticals Inc 20.00 k 3.95 m 3.70
Vertex Pharmaceuticals Inc 28.50 k 3.85 m 3.60
BioMarin Pharmaceutical Inc 25.00 k 3.66 m 3.42
Mylan NV 59.00 k 3.30 m 3.09
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00